Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neuroradiology

01-10-2012 | Diagnostic Neuroradiology

Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels

Authors: Takeshi Sawada, Akira Yamamoto, Yukio Miki, Ken-ichiro Kikuta, Tomohisa Okada, Mitsunori Kanagaki, Seiko Kasahara, Susumu Miyamoto, Jun C. Takahashi, Hidenao Fukuyama, Kaori Togashi

Published in: Neuroradiology | Issue 10/2012

Login to get access

Abstract

Introduction

The purpose of this study was to propose new magnetic resonance (MR) criteria of diagnosing moyamoya disease (MMD) from cisternal moyamoya vessels (MMVs) on 3-T magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA) and compare the diagnostic accuracy of the existing MR criteria and the proposed MR criteria.

Methods

Participants comprised 20 consecutive patients with MMD (4 males, 16 females) diagnosed clinically using conventional angiography and 20 controls (13 male and 7 female arteriosclerosis patients). In these participants, 3-T MRI/MRA was evaluated by the existing MR criteria, which use MMVs in the basal ganglia, and the proposed MR criteria, which use cisternal MMVs, and then these two criteria were statistically compared by McNemar’s test.

Results

Diagnostic accuracy was 62.5% with the existing MR criteria and 97.5% with the proposed MR criteria. The proposed MR criteria was more sensitive (1.00) than the existing MR criteria (0.45), but less specific (0.95) than the existing MR criteria (1.00).

Conclusion

The proposed MR criteria using cisternal MMVs showed significantly higher diagnostic accuracy than the existing MR criteria. We believe that our proposed MR criteria will be beneficial for diagnosing MMD.
Literature
1.
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288–299PubMedCrossRef
2.
3.
4.
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6(7):e22542. doi:10.​1371/​journal.​pone.​0022542 PubMedCrossRef
5.
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240PubMed
6.
7.
Serdaru M, Gray F, Merland JJ, Escourolle R, Grumbach R (1979) Moyamoya disease and intracerebral hematoma. Clinical pathological report. Neuroradiology 18(1):47–52PubMedCrossRef
8.
9.
10.
11.
Houkin K, Aoki T, Takahashi A, Abe H (1994) Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 25(11):2159–2164PubMedCrossRef
12.
13.
Tanenbaum LN (2004) 3-T MR imaging: ready for clinical practice. AJNR Am J Neuroradiol 25(9):1626–1627, author reply 1629PubMed
14.
Thomas SD, Al-Kwifi O, Emery DJ, Wilman AH (2002) Application of magnetization transfer at 3.0 T in three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. J Magn Reson Imaging 15(4):479–483. doi:10.​1002/​Jmri.​10085 PubMedCrossRef
15.
Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, Nozaki K, Hashimoto N, Hanakawa T, Fukuyama H, Togashi K (2006) Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology 239(1):232–237. doi:10.​1148/​radiol.​2383042020 PubMedCrossRef
16.
Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N (2005) Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102(3):470–475. doi:10.​3171/​jns.​2005.​102.​3.​0470 PubMedCrossRef
17.
Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, Sawamoto N, Fukuyama H, Hashimoto N, Togashi K (2008) Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol 43(8):574–579. doi:10.​1097/​RLI.​0b013e31817fb432​ PubMedCrossRef
18.
Illner A (2009) Moyamoya. In: Osborn AG, Salzman KL, Barkovich AJ (eds) Diagnostic imaging: brain, 2nd edn. Lippincott Williams & Wilkins, Salt Lake City, pp I-4-46–I-4-49
19.
Maeda M, Tsuchida C (1999) “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. Am J Neuroradiol 20(10):1836–1838PubMed
20.
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111(5):927–935. doi:10.​3171/​2009.​4.​JNS081649 PubMedCrossRef
21.
Hanley JA, Mcneil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843PubMed
22.
McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12(2):153–157PubMedCrossRef
23.
24.
Fujisawa I, Asato R, Nishimura K, Togashi K, Itoh K, Noma S, Sagoh T, Minami S, Nakano Y, Yonekawa Y et al (1987) Moyamoya disease: MR imaging. Radiology 164(1):103–105PubMed
25.
Yamada I, Matsushima Y, Suzuki S (1992) Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology 184(3):773–778PubMed
26.
Battistella PA, Carollo C, Pellegrino PA, Soriani S, Scarpa P (1995) Magnetic resonance angiography in moyamoya disease. Childs Nerv Syst 11(6):329–334PubMedCrossRef
27.
Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20(5):347–354. doi:10.​1159/​000087935 PubMedCrossRef
28.
Yamada I, Suzuki S, Matsushima Y (1995) Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology 37(5):356–361PubMedCrossRef
29.
30.
Komiyama M, Ishiguro T, Nishikawa M, Yasui T, Morikawa T, Kitano S, Sakamoto H (2002) Constructive interference in steady state imaging of moyamoya disease. Neurol Med Chir (Tokyo) 42(1):11–16, discussion 17CrossRef
31.
32.
33.
34.
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(2):142–149PubMed
35.
Metadata
Title
Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels
Authors
Takeshi Sawada
Akira Yamamoto
Yukio Miki
Ken-ichiro Kikuta
Tomohisa Okada
Mitsunori Kanagaki
Seiko Kasahara
Susumu Miyamoto
Jun C. Takahashi
Hidenao Fukuyama
Kaori Togashi
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 10/2012
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-012-1020-1